| (S)-nicotine | decreases expression | EXP | | 6480464 | Nicotine results in decreased expression of BAD mRNA | CTD | PMID:18247414 |
| (S)-nicotine | decreases phosphorylation | ISO | RGD:620103 | 6480464 | Nicotine results in decreased phosphorylation of BAD protein | CTD | PMID:20447445 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:620103 | 6480464 | Ethinyl Estradiol results in decreased expression of BAD mRNA | CTD | PMID:16940010 |
| 17beta-estradiol | multiple interactions | ISO | RGD:620103 | 6480464 | Estradiol inhibits the reaction [Dimethylnitrosamine results in increased expression of BAD protein] | CTD | PMID:14659978 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of BAD mRNA | CTD | PMID:23373633 |
| 1H-pyrazole | multiple interactions | ISO | RGD:620103 | 6480464 | [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAD mRNA | CTD | PMID:16610055 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAD mRNA | CTD | PMID:17823287 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733062 | 6480464 | Tetrachlorodibenzodioxin affects the expression of BAD mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733062 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAD mRNA | CTD | PMID:17823287 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733062 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAD mRNA | CTD | PMID:17823287 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733062 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAD mRNA | CTD | PMID:12167310 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733062 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAD mRNA | CTD | PMID:12167310 more ... |
| 2-naphthylamine | decreases expression | EXP | | 6480464 | 2-Naphthylamine results in decreased expression of BAD mRNA | CTD | PMID:18247414 |
| 3,3',5-triiodo-L-thyronine | decreases expression | EXP | | 6480464 | Triiodothyronine results in decreased expression of BAD protein | CTD | PMID:16021636 |
| 3,3',5-triiodo-L-thyronine | decreases expression | ISO | RGD:620103 | 6480464 | Triiodothyronine results in decreased expression of BAD protein | CTD | PMID:16021636 |
| 3,3'-diindolylmethane | decreases phosphorylation | EXP | | 6480464 | 3,3'-diindolylmethane results in decreased phosphorylation of BAD protein | CTD | PMID:22290291 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:733062 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of BAD mRNA | CTD | PMID:20188158 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of BAD protein | CTD | PMID:18508827 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | EXP | | 6480464 | SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of BAD protein]; more ... | CTD | PMID:18508827 |
| 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of BAD mRNA | CTD | PMID:12419474 |
| 5-azacytidine | increases expression | ISO | RGD:620103 | 6480464 | Azacitidine results in increased expression of BAD mRNA | CTD | PMID:21224363 |
| 5-azacytidine | multiple interactions | ISO | RGD:620103 | 6480464 | [Azacitidine co-treated with N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide] results in increased expression of BAD mRNA; more ... | CTD | PMID:21224363 |
| acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of BAD mRNA | CTD | PMID:20457246 |
| acrolein | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased phosphorylation of BAD protein]; more ... | CTD | PMID:19596284 |
| acrolein | increases expression | ISO | RGD:733062 | 6480464 | Acrolein results in increased expression of BAD mRNA | CTD | PMID:18515264 |
| acrolein | increases phosphorylation | EXP | | 6480464 | Acrolein results in increased phosphorylation of BAD protein | CTD | PMID:19596284 |
| all-trans-retinoic acid | decreases phosphorylation | EXP | | 6480464 | Tretinoin results in decreased phosphorylation of BAD protein | CTD | PMID:16411021 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of BAD protein | CTD | PMID:17387344 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with zoledronic acid] results in increased expression of BAD protein | CTD | PMID:20349282 |
| ammonium chloride | affects expression | ISO | RGD:620103 | 6480464 | Ammonium Chloride affects the expression of BAD mRNA | CTD | PMID:16483693 |
| ammonium chloride | decreases phosphorylation | ISO | RGD:620103 | 6480464 | Ammonium Chloride results in decreased phosphorylation of BAD protein | CTD | PMID:15036616 PMID:14535961 |
| ammonium chloride | multiple interactions | ISO | RGD:620103 | 6480464 | Cyclosporine inhibits the reaction [Ammonium Chloride results in decreased phosphorylation of BAD protein]; more ... | CTD | PMID:15036616 |
| ammonium chloride | multiple interactions | ISO | RGD:620103 | 6480464 | 4-aminocrotonic acid inhibits the reaction [Ammonium Chloride results in decreased phosphorylation of BAD protein] | CTD | PMID:14535961 |
| ammonium chloride | decreases phosphorylation | ISO | RGD:620103 | 6480464 | Ammonium Chloride results in decreased phosphorylation of BAD protein | CTD | PMID:14535961 PMID:15036616 |
| arsenite(3-) | decreases expression | ISO | RGD:733062 | 6480464 | arsenite results in decreased expression of BAD mRNA | CTD | PMID:15345372 |
| azadirachtin A | increases expression | EXP | | 6480464 | azadirachtin results in increased expression of BAD mRNA | CTD | PMID:20429769 |
| benzene | increases expression | ISO | RGD:620103 | 6480464 | Benzene results in increased expression of BAD protein | CTD | PMID:18093815 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of BAD protein | CTD | PMID:15698582 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of BAD mRNA | CTD | PMID:18247414 |
| benzo[a]pyrene | increases phosphorylation | EXP | | 6480464 | Benzo(a)pyrene results in increased phosphorylation of BAD protein | CTD | PMID:15698582 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:733062 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of BAD mRNA | CTD | PMID:21715664 |
| benzo[b]fluoranthene | increases expression | ISO | RGD:733062 | 6480464 | benzo(b)fluoranthene results in increased expression of BAD protein | CTD | PMID:21392559 |
| bis(2-chloroethyl) sulfide | multiple interactions | EXP | | 6480464 | N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide inhibits the reaction [Mustard Gas results in decreased phosphorylation of BAD protein] | CTD | PMID:16935404 |
| bis(2-chloroethyl) sulfide | decreases phosphorylation | EXP | | 6480464 | Mustard Gas results in decreased phosphorylation of BAD protein | CTD | PMID:16935404 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of BAD protein | CTD | PMID:21277958 |
| cadmium dichloride | multiple interactions | ISO | RGD:733062 | 6480464 | arjunolic acid inhibits the reaction [Cadmium Chloride results in increased expression of BAD protein] | CTD | PMID:21420465 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of BAD mRNA | CTD | PMID:19426795 |
| cadmium dichloride | increases expression | ISO | RGD:733062 | 6480464 | Cadmium Chloride results in increased expression of BAD protein | CTD | PMID:21420465 |
| calciol | increases phosphorylation | EXP | | 6480464 | Cholecalciferol results in increased phosphorylation of BAD protein | CTD | PMID:18628207 |
| calciol | multiple interactions | EXP | | 6480464 | [Cholecalciferol results in increased phosphorylation of BAD protein] inhibits the reaction [BAD protein binds to BCL2L1 protein] | CTD | PMID:18628207 |
| calcium atom | affects expression | ISO | RGD:620103 | 6480464 | Calcium affects the expression of BAD mRNA | CTD | PMID:15913539 |
| calcium(0) | affects expression | ISO | RGD:620103 | 6480464 | Calcium affects the expression of BAD mRNA | CTD | PMID:15913539 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of BAD mRNA | CTD | PMID:19502594 |
| carbon monoxide | multiple interactions | ISO | RGD:733062 | 6480464 | Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of BAD protein] | CTD | PMID:18037988 |
| ciglitazone | increases expression | ISO | RGD:620103 | 6480464 | ciglitazone results in increased expression of BAD protein | CTD | PMID:12065618 |
| cisplatin | decreases response to substance | EXP | | 6480464 | BAD protein modified form results in decreased susceptibility to Cisplatin; more ... | CTD | PMID:21849418 |
| cisplatin | multiple interactions | EXP | | 6480464 | Y 27632 inhibits the reaction [Cisplatin results in increased expression of BAD mRNA] | CTD | PMID:20878077 |
| cisplatin | multiple interactions | EXP | | 6480464 | [PPM1A results in decreased phosphorylation of BAD protein] which results in increased susceptibility to Cisplatin; more ... | CTD | PMID:21849418 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [Metformin results in increased expression of BAD protein] | CTD | PMID:21388661 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BAD mRNA | CTD | PMID:20878077 |
| cocaine | affects expression | ISO | RGD:733062 | 6480464 | Cocaine affects the expression of BAD mRNA | CTD | PMID:15681117 |
| copper atom | decreases phosphorylation | ISO | RGD:733062 | 6480464 | Copper analog results in decreased phosphorylation of BAD protein | CTD | PMID:22000994 |
| copper(0) | decreases phosphorylation | ISO | RGD:733062 | 6480464 | Copper analog results in decreased phosphorylation of BAD protein | CTD | PMID:22000994 |
| cordycepin | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [cordycepin results in increased expression of BAD protein] | CTD | PMID:21310227 |
| cordycepin | increases expression | EXP | | 6480464 | cordycepin results in increased expression of BAD protein | CTD | PMID:21310227 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of BAD mRNA; more ... | CTD | PMID:19235267 |
| curcumin | multiple interactions | ISO | RGD:620103 | 6480464 | Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAD protein] | CTD | PMID:15569404 |
| cyclophosphamide | increases expression | ISO | RGD:620103 | 6480464 | Cyclophosphamide results in increased expression of BAD mRNA | CTD | PMID:11599041 |
| cyclosporin A | multiple interactions | ISO | RGD:620103 | 6480464 | Cyclosporine inhibits the reaction [Ammonium Chloride results in decreased phosphorylation of BAD protein] | CTD | PMID:15036616 |
| cyclosporin A | multiple interactions | ISO | RGD:733062 | 6480464 | Cyclosporine results in increased expression of and results in increased phosphorylation of BAD protein | CTD | PMID:22155090 |
| cyclosporin A | decreases activity | ISO | RGD:733062 | 6480464 | Cyclosporine results in decreased activity of BAD protein | CTD | PMID:22155090 |
| D-glucose | multiple interactions | ISO | RGD:733062 | 6480464 | Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein; more ... | CTD | PMID:20370652 |
| D-mannitol | increases phosphorylation | ISO | RGD:620103 | 6480464 | Mannitol results in increased phosphorylation of BAD protein | CTD | PMID:15786717 |
| D-mannitol | multiple interactions | ISO | RGD:620103 | 6480464 | wortmannin inhibits the reaction [Mannitol results in increased phosphorylation of BAD protein] | CTD | PMID:15786717 |
| dehydroepiandrosterone | increases expression | ISO | RGD:620103 | 6480464 | Dehydroepiandrosterone results in increased expression of BAD mRNA | CTD | PMID:16940010 |
| Delta(9)-tetrahydrocannabinol | decreases phosphorylation | EXP | | 6480464 | Tetrahydrocannabinol results in decreased phosphorylation of BAD protein | CTD | PMID:17583570 |
| Delta(9)-tetrahydrocannabinol | increases response to substance | EXP | | 6480464 | BAD results in increased susceptibility to Tetrahydrocannabinol | CTD | PMID:17583570 |
| dexamethasone | decreases phosphorylation | ISO | RGD:733062 | 6480464 | Dexamethasone results in decreased phosphorylation of BAD protein | CTD | PMID:16644695 |
| dexamethasone | multiple interactions | ISO | RGD:733062 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone results in decreased phosphorylation of BAD protein]; more ... | CTD | PMID:16644695 |
| dexamethasone | increases expression | ISO | RGD:733062 | 6480464 | Dexamethasone results in increased expression of BAD mRNA | CTD | PMID:16644695 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of BAD protein | CTD | PMID:18349030 |
| diarsenic trioxide | affects expression | ISO | RGD:620103 | 6480464 | arsenic trioxide affects the expression of BAD protein | CTD | PMID:18618274 |
| diarsenic trioxide | decreases expression | ISO | RGD:733062 | 6480464 | arsenic trioxide results in decreased expression of BAD mRNA | CTD | PMID:15073043 |
| diarsenic trioxide | decreases expression | ISO | RGD:620103 | 6480464 | arsenic trioxide results in decreased expression of BAD mRNA | CTD | PMID:19730151 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | arsenic trioxide results in increased phosphorylation of and results in increased activity of BAD protein | CTD | PMID:18387645 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of BAD protein | CTD | PMID:19364129 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of BAD mRNA | CTD | PMID:17530438 |
| dibutyl phthalate | decreases expression | ISO | RGD:620103 | 6480464 | Dibutyl Phthalate results in decreased expression of BAD mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:733062 | 6480464 | Dibutyl Phthalate results in decreased expression of BAD mRNA | CTD | PMID:21266533 |
| diethanolamine | decreases expression | ISO | RGD:733062 | 6480464 | diethanolamine results in decreased expression of BAD mRNA | CTD | PMID:16014740 |
| diethanolamine | decreases expression | ISO | RGD:620103 | 6480464 | diethanolamine results in decreased expression of BAD mRNA | CTD | PMID:16014740 |
| diethylstilbestrol | increases expression | ISO | RGD:733062 | 6480464 | Diethylstilbestrol results in increased expression of BAD mRNA | CTD | PMID:15545218 |
| dimethylarsinic acid | increases expression | ISO | RGD:620103 | 6480464 | Cacodylic Acid results in increased expression of BAD mRNA | CTD | PMID:16122865 |
| dimethylarsinic acid | increases expression | ISO | RGD:733062 | 6480464 | Cacodylic Acid results in increased expression of BAD mRNA; more ... | CTD | PMID:22246474 |
| docetaxel anhydrous | decreases phosphorylation | EXP | | 6480464 | docetaxel results in decreased phosphorylation of BAD protein | CTD | PMID:17317842 |
| docetaxel anhydrous | multiple interactions | EXP | | 6480464 | U 0126 promotes the reaction [docetaxel results in decreased phosphorylation of BAD protein] | CTD | PMID:17317842 |
| doxorubicin | multiple interactions | EXP | | 6480464 | sildenafil promotes the reaction [Doxorubicin results in decreased phosphorylation of BAD protein] | CTD | PMID:20884855 |
| doxorubicin | decreases phosphorylation | EXP | | 6480464 | Doxorubicin results in decreased phosphorylation of BAD protein | CTD | PMID:20884855 PMID:17359293 |
| doxorubicin | decreases phosphorylation | ISO | RGD:733062 | 6480464 | Doxorubicin results in decreased phosphorylation of BAD protein | CTD | PMID:18948619 PMID:18037988 |
| doxorubicin | increases expression | ISO | RGD:620103 | 6480464 | Doxorubicin results in increased expression of BAD protein | CTD | PMID:12967636 PMID:18632596 |
| doxorubicin | multiple interactions | EXP | | 6480464 | PTEN protein promotes the reaction [Doxorubicin results in decreased phosphorylation of BAD protein] | CTD | PMID:17359293 |
| doxorubicin | decreases phosphorylation | EXP | | 6480464 | Doxorubicin results in decreased phosphorylation of BAD protein | CTD | PMID:17359293 PMID:20884855 |
| doxorubicin | multiple interactions | EXP | | 6480464 | PTEN protein promotes the reaction [Doxorubicin results in decreased expression of BAD protein modified form] | CTD | PMID:16438844 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of BAD protein modified form | CTD | PMID:16438844 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin promotes the reaction [MAPK14 protein results in decreased phosphorylation of BAD protein] | CTD | PMID:16843435 |
| doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of BAD mRNA | CTD | PMID:16705698 |
| doxorubicin | multiple interactions | ISO | RGD:620103 | 6480464 | Ginkgo biloba extract 761 inhibits the reaction [Doxorubicin results in increased expression of BAD protein] | CTD | PMID:18632596 |
| doxorubicin | multiple interactions | ISO | RGD:620103 | 6480464 | HSPD1 protein inhibits the reaction [Doxorubicin results in increased expression of BAD protein] | CTD | PMID:12967636 |
| doxorubicin | multiple interactions | ISO | RGD:620103 | 6480464 | HMOX1 protein inhibits the reaction [Doxorubicin results in increased phosphorylation of BAD protein] | CTD | PMID:18845810 |
| doxorubicin | increases phosphorylation | ISO | RGD:620103 | 6480464 | Doxorubicin results in increased phosphorylation of BAD protein | CTD | PMID:18845810 |
| doxorubicin | increases expression | ISO | RGD:620103 | 6480464 | Doxorubicin results in increased expression of BAD protein | CTD | PMID:18632596 PMID:12967636 |
| doxorubicin | decreases phosphorylation | ISO | RGD:733062 | 6480464 | Doxorubicin results in decreased phosphorylation of BAD protein | CTD | PMID:18037988 PMID:18948619 |
| doxorubicin | multiple interactions | ISO | RGD:733062 | 6480464 | Doxycycline inhibits the reaction [Doxorubicin results in increased expression of BAD protein] | CTD | PMID:17673183 |
| doxorubicin | increases expression | ISO | RGD:733062 | 6480464 | Doxorubicin results in increased expression of BAD protein | CTD | PMID:17673183 |
| doxorubicin | multiple interactions | ISO | RGD:733062 | 6480464 | Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of BAD protein] | CTD | PMID:18037988 |
| doxycycline | multiple interactions | ISO | RGD:733062 | 6480464 | Doxycycline inhibits the reaction [Doxorubicin results in increased expression of BAD protein] | CTD | PMID:17673183 |
| ethanol | increases expression | ISO | RGD:620103 | 6480464 | Ethanol results in increased expression of BAD mRNA | CTD | PMID:20655511 |
| ethanol | multiple interactions | ISO | RGD:620103 | 6480464 | [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAD mRNA | CTD | PMID:16610055 |
| eugenol | multiple interactions | ISO | RGD:733062 | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAD mRNA] | CTD | PMID:20434464 |
| fluoxetine | increases expression | ISO | RGD:733062 | 6480464 | Fluoxetine results in increased expression of BAD mRNA | CTD | PMID:21497159 |
| flutamide | increases expression | ISO | RGD:620103 | 6480464 | Flutamide results in increased expression of BAD protein modified form | CTD | PMID:20850791 |
| furosemide | affects expression | ISO | RGD:620103 | 6480464 | Furosemide affects the expression of BAD mRNA | CTD | PMID:17497460 |
| glucose | multiple interactions | ISO | RGD:733062 | 6480464 | Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein; more ... | CTD | PMID:20370652 |
| hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of BAD mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | increases expression | ISO | RGD:620103 | 6480464 | Hydrogen Peroxide results in increased expression of BAD mRNA | CTD | PMID:14689451 |
| hydroquinone | decreases expression | EXP | | 6480464 | hydroquinone results in decreased expression of BAD mRNA | CTD | PMID:15452088 |
| imatinib | multiple interactions | EXP | | 6480464 | [imatinib co-treated with flavopiridol] results in decreased expression of BAD protein; more ... | CTD | PMID:12231544 |
| indomethacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of BAD protein | CTD | PMID:18678619 |
| indomethacin | multiple interactions | EXP | | 6480464 | [Indomethacin results in decreased expression of YWHAE protein] which results in increased localization of BAD protein | CTD | PMID:17409426 |
| isoflurane | decreases expression | ISO | RGD:620103 | 6480464 | Isoflurane results in decreased expression of BAD mRNA | CTD | PMID:16978161 |
| L-ascorbic acid | multiple interactions | ISO | RGD:620103 | 6480464 | Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased phosphorylation of BAD protein]; more ... | CTD | PMID:21262251 |
| lead diacetate | affects expression | ISO | RGD:620103 | 6480464 | lead acetate affects the expression of BAD protein | CTD | PMID:18618274 |
| LY294002 | decreases phosphorylation | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of BAD protein | CTD | PMID:14628071 PMID:12970779 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [polyphenon E results in decreased phosphorylation of BAD protein]; more ... | CTD | PMID:23285096 |
| LY294002 | decreases phosphorylation | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of BAD protein | CTD | PMID:12970779 more ... |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased phosphorylation of BAD protein] | CTD | PMID:19596284 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Simvastatin results in decreased phosphorylation of BAD protein] | CTD | PMID:12438947 |
| LY294002 | multiple interactions | ISO | RGD:620103 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Rotenone results in increased phosphorylation of BAD protein]] | CTD | PMID:17123556 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tauroursodeoxycholic acid results in increased phosphorylation of and results in decreased activity of BAD protein] | CTD | PMID:17559149 |
| LY294002 | decreases phosphorylation | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of BAD protein | CTD | PMID:12970779 PMID:14628071 |
| maneb | multiple interactions | EXP | | 6480464 | [Paraquat co-treated with Maneb] results in increased phosphorylation of BAD protein | CTD | PMID:15824117 |
| melamine | multiple interactions | EXP | | 6480464 | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [melamine results in increased expression of BAD protein]; more ... | CTD | PMID:22915474 |
| melamine | increases expression | EXP | | 6480464 | melamine results in increased expression of BAD protein | CTD | PMID:22915474 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin promotes the reaction [YWHAB protein binds to BAD protein] | CTD | PMID:18078454 |
| melatonin | increases phosphorylation | EXP | | 6480464 | Melatonin results in increased phosphorylation of BAD protein | CTD | PMID:18078454 |
| melatonin | multiple interactions | ISO | RGD:733062 | 6480464 | Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of BAD protein] | CTD | PMID:21138475 |
| mercury atom | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of BAD mRNA | CTD | PMID:19937285 |
| mercury dichloride | increases expression | ISO | RGD:733062 | 6480464 | Mercuric Chloride results in increased expression of BAD protein | CTD | PMID:21373768 |
| mercury(0) | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of BAD mRNA | CTD | PMID:19937285 |
| metformin | increases expression | EXP | | 6480464 | Metformin results in increased expression of BAD protein | CTD | PMID:21388661 |
| metformin | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [Metformin results in increased expression of BAD protein] | CTD | PMID:21388661 |
| mifepristone | multiple interactions | ISO | RGD:733062 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone results in decreased phosphorylation of BAD protein]; more ... | CTD | PMID:16644695 |
| mifepristone | multiple interactions | ISO | RGD:620103 | 6480464 | Mifepristone inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Rotenone results in increased phosphorylation of BAD protein]] | CTD | PMID:17123556 |
| mitomycin C | increases expression | EXP | | 6480464 | Mitomycin results in increased expression of BAD protein | CTD | PMID:16186332 |
| monodansylcadaverine | decreases expression | EXP | | 6480464 | monodansylcadaverine results in decreased expression of BAD protein | CTD | PMID:16170020 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [nickel acetate results in increased expression of BAD protein] | CTD | PMID:22245127 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [cordycepin results in increased expression of BAD protein] | CTD | PMID:21310227 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases expression | ISO | RGD:733062 | 6480464 | Methylnitronitrosoguanidine results in decreased expression of BAD mRNA | CTD | PMID:20434464 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:733062 | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAD mRNA] | CTD | PMID:20434464 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:620103 | 6480464 | Dimethylnitrosamine results in increased expression of BAD protein | CTD | PMID:14659978 |
| N-nitrosodimethylamine | multiple interactions | ISO | RGD:620103 | 6480464 | Estradiol inhibits the reaction [Dimethylnitrosamine results in increased expression of BAD protein]; more ... | CTD | PMID:14659978 |
| nickel dichloride | increases expression | ISO | RGD:620103 | 6480464 | nickel chloride results in increased expression of BAD protein | CTD | PMID:20391133 |
| ochratoxin A | increases expression | ISO | RGD:620103 | 6480464 | ochratoxin A results in increased expression of BAD mRNA | CTD | PMID:19562491 |
| paclitaxel | increases expression | EXP | | 6480464 | Paclitaxel results in increased expression of BAD protein; more ... | CTD | PMID:10822281 |
| paclitaxel | multiple interactions | EXP | | 6480464 | [PD168393 co-treated with Paclitaxel] results in increased expression of BAD protein | CTD | PMID:16413505 |
| paraquat | multiple interactions | EXP | | 6480464 | [Paraquat co-treated with Maneb] results in increased phosphorylation of BAD protein | CTD | PMID:15824117 |
| paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of BAD mRNA | CTD | PMID:18836921 |
| paraquat | increases expression | ISO | RGD:620103 | 6480464 | Paraquat results in increased expression of BAD mRNA | CTD | PMID:17935786 |
| pentachlorophenol | increases expression | ISO | RGD:620103 | 6480464 | Pentachlorophenol results in increased expression of BAD mRNA | CTD | PMID:19442831 |
| phenobarbital | decreases expression | ISO | RGD:620103 | 6480464 | Phenobarbital results in decreased expression of BAD mRNA | CTD | PMID:16940010 |
| pirinixic acid | increases expression | ISO | RGD:733062 | 6480464 | pirinixic acid results in increased expression of BAD mRNA | CTD | PMID:15618236 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of BAD mRNA | CTD | PMID:19710929 |
| potassium dichromate | multiple interactions | ISO | RGD:620103 | 6480464 | Ascorbic Acid inhibits the reaction [Potassium Dichromate affects the localization of BAD protein]; more ... | CTD | PMID:21262251 |
| potassium dichromate | increases expression | ISO | RGD:620103 | 6480464 | Potassium Dichromate results in increased expression of BAD protein | CTD | PMID:21262251 |
| potassium dichromate | decreases phosphorylation | ISO | RGD:620103 | 6480464 | Potassium Dichromate results in decreased phosphorylation of BAD protein | CTD | PMID:21262251 |
| pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:620103 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of BAD mRNA | CTD | PMID:19162173 |
| progesterone | decreases expression | ISO | RGD:620103 | 6480464 | Progesterone results in decreased expression of BAD mRNA | CTD | PMID:15941375 |
| pterostilbene | increases expression | ISO | RGD:733062 | 6480464 | pterostilbene results in increased expression of BAD protein | CTD | PMID:20681671 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of BAD protein | CTD | PMID:14767529 |
| raloxifene | increases cleavage | EXP | | 6480464 | Raloxifene results in increased cleavage of BAD protein | CTD | PMID:12084714 |
| resveratrol | multiple interactions | ISO | RGD:733062 | 6480464 | [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein] | CTD | PMID:20370652 |
| resveratrol | multiple interactions | ISO | RGD:620103 | 6480464 | [8-cyclopentyl-1,3-dimethylxanthine results in decreased activity of ADORA1 protein] inhibits the reaction [resveratrol results in increased phosphorylation of BAD protein]; more ... | CTD | PMID:15345477 |
| resveratrol | increases phosphorylation | ISO | RGD:620103 | 6480464 | resveratrol results in increased phosphorylation of BAD protein | CTD | PMID:15345477 |
| resveratrol | decreases expression | ISO | RGD:733062 | 6480464 | resveratrol results in decreased expression of BAD protein | CTD | PMID:17872969 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BAD protein | CTD | PMID:16731767 |
| resveratrol | increases expression | ISO | RGD:733062 | 6480464 | resveratrol results in increased expression of BAD mRNA | CTD | PMID:22610192 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of BAD mRNA | CTD | PMID:17639046 |
| rotenone | decreases phosphorylation | EXP | | 6480464 | Rotenone results in decreased phosphorylation of BAD protein | CTD | PMID:15280438 |
| rotenone | increases phosphorylation | ISO | RGD:620103 | 6480464 | Rotenone results in increased phosphorylation of BAD protein | CTD | PMID:17123556 |
| rotenone | multiple interactions | EXP | | 6480464 | Tacrolimus inhibits the reaction [Rotenone results in decreased phosphorylation of BAD protein] | CTD | PMID:15280438 |
| rotenone | multiple interactions | ISO | RGD:620103 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Rotenone results in increased phosphorylation of BAD protein]]; more ... | CTD | PMID:17123556 |
| ruthenium atom | decreases phosphorylation | EXP | | 6480464 | Ruthenium results in decreased phosphorylation of BAD protein | CTD | PMID:17210701 |
| sildenafil | multiple interactions | EXP | | 6480464 | sildenafil promotes the reaction [Doxorubicin results in decreased phosphorylation of BAD protein] | CTD | PMID:20884855 |
| simvastatin | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Simvastatin results in decreased phosphorylation of BAD protein] | CTD | PMID:12438947 |
| simvastatin | decreases phosphorylation | EXP | | 6480464 | Simvastatin results in decreased phosphorylation of BAD protein | CTD | PMID:12438947 |
| sirolimus | multiple interactions | ISO | RGD:733062 | 6480464 | Sirolimus inhibits the reaction [IL2 protein results in increased expression of BAD mRNA] | CTD | PMID:11355896 |
| sodium fluoride | multiple interactions | EXP | | 6480464 | Sodium Fluoride inhibits the reaction [CA2 protein binds to BAD protein]; more ... | CTD | PMID:21708216 |
| spironolactone | increases phosphorylation | ISO | RGD:620103 | 6480464 | Spironolactone results in increased phosphorylation of BAD protein | CTD | PMID:19114643 |
| spironolactone | decreases expression | ISO | RGD:620103 | 6480464 | Spironolactone results in decreased expression of BAD protein | CTD | PMID:19114643 |
| streptozocin | multiple interactions | ISO | RGD:620103 | 6480464 | arjunolic acid inhibits the reaction [Streptozocin results in increased expression of BAD protein] | CTD | PMID:19682444 |
| streptozocin | multiple interactions | ISO | RGD:620103 | 6480464 | Streptozocin results in increased phosphorylation of and results in decreased activity of BAD protein | CTD | PMID:15976052 |
| streptozocin | increases expression | ISO | RGD:620103 | 6480464 | Streptozocin results in increased expression of BAD protein | CTD | PMID:19682444 |
| streptozocin | decreases expression | ISO | RGD:620103 | 6480464 | Streptozocin results in decreased expression of BAD protein | CTD | PMID:15976052 |
| sulindac | multiple interactions | EXP | | 6480464 | Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of BAD protein] | CTD | PMID:12566304 |
| sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of BAD protein | CTD | PMID:12566304 |
| tacrolimus hydrate | multiple interactions | ISO | RGD:620103 | 6480464 | Tacrolimus inhibits the reaction [Ammonium Chloride results in decreased phosphorylation of BAD protein] | CTD | PMID:15036616 |
| tacrolimus hydrate | multiple interactions | EXP | | 6480464 | Tacrolimus inhibits the reaction [Rotenone results in decreased phosphorylation of BAD protein] | CTD | PMID:15280438 |
| tamoxifen | increases phosphorylation | EXP | | 6480464 | Tamoxifen results in increased phosphorylation of BAD protein | CTD | PMID:17186241 |
| taurine | multiple interactions | ISO | RGD:620103 | 6480464 | Taurine inhibits the reaction [sodium arsenite results in increased expression of BAD protein] | CTD | PMID:19616567 |
| taurine | multiple interactions | ISO | RGD:620103 | 6480464 | Taurine inhibits the reaction [sodium arsenite results in increased expression of BAD protein] | CTD | PMID:19429265 more ... |
| taurine | multiple interactions | ISO | RGD:620103 | 6480464 | Taurine inhibits the reaction [Alloxan results in increased expression of BAD protein] | CTD | PMID:22138235 |
| taurine | multiple interactions | ISO | RGD:620103 | 6480464 | Taurine inhibits the reaction [sodium arsenite results in increased expression of BAD protein] | CTD | PMID:19429265 PMID:19616567 |
| tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of BAD mRNA | CTD | PMID:12419474 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:620103 | 6480464 | tert-Butylhydroperoxide results in increased expression of BAD protein | CTD | PMID:15569404 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:620103 | 6480464 | Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAD protein] | CTD | PMID:15569404 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of BAD protein | CTD | PMID:17419000 |
| testosterone | increases expression | ISO | RGD:620103 | 6480464 | Testosterone deficiency results in increased expression of BAD protein modified form | CTD | PMID:20850791 |
| tetrachloromethane | decreases expression | ISO | RGD:620103 | 6480464 | Carbon Tetrachloride results in decreased expression of BAD mRNA | CTD | PMID:16644059 |
| tetrachloromethane | multiple interactions | ISO | RGD:620103 | 6480464 | [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAD mRNA | CTD | PMID:16610055 |
| thioacetamide | increases expression | ISO | RGD:620103 | 6480464 | Thioacetamide results in increased expression of BAD protein | CTD | PMID:16937528 |
| titanium dioxide | affects expression | EXP | | 6480464 | titanium dioxide affects the expression of BAD mRNA | CTD | PMID:19695317 |
| trans-resveratrol | multiple interactions | ISO | RGD:733062 | 6480464 | [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein] | CTD | PMID:20370652 |
| trans-resveratrol | multiple interactions | ISO | RGD:620103 | 6480464 | [8-cyclopentyl-1,3-dimethylxanthine results in decreased activity of ADORA1 protein] inhibits the reaction [resveratrol results in increased phosphorylation of BAD protein]; more ... | CTD | PMID:15345477 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:620103 | 6480464 | resveratrol results in increased phosphorylation of BAD protein | CTD | PMID:15345477 |
| trans-resveratrol | decreases expression | ISO | RGD:733062 | 6480464 | resveratrol results in decreased expression of BAD protein | CTD | PMID:17872969 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BAD protein | CTD | PMID:16731767 |
| trans-resveratrol | increases expression | ISO | RGD:733062 | 6480464 | resveratrol results in increased expression of BAD mRNA | CTD | PMID:22610192 |
| triamcinolone acetonide | increases expression | ISO | RGD:620103 | 6480464 | Triamcinolone Acetonide results in increased expression of BAD protein | CTD | PMID:15987869 |
| trichloroethene | multiple interactions | ISO | RGD:733062 | 6480464 | PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of BAD protein] | CTD | PMID:15363585 |
| trichloroethene | increases expression | ISO | RGD:733062 | 6480464 | Trichloroethylene results in increased expression of BAD mRNA | CTD | PMID:15363585 |
| valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of BAD mRNA | CTD | PMID:17183730 |
| valproic acid | affects expression | ISO | RGD:620103 | 6480464 | Valproic Acid affects the expression of BAD protein | CTD | PMID:15379904 |
| wortmannin | multiple interactions | ISO | RGD:620103 | 6480464 | wortmannin inhibits the reaction [Mannitol results in increased phosphorylation of BAD protein] | CTD | PMID:15786717 |
| wortmannin | decreases phosphorylation | ISO | RGD:620103 | 6480464 | wortmannin results in decreased phosphorylation of BAD protein | CTD | PMID:15190125 |
| wortmannin | multiple interactions | ISO | RGD:620103 | 6480464 | wortmannin inhibits the reaction [tauroursodeoxycholic acid results in increased phosphorylation of and affects the localization of BAD protein] | CTD | PMID:15190125 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [Acrolein results in increased phosphorylation of BAD protein] | CTD | PMID:19596284 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of BAD protein] | CTD | PMID:15608143 |
| zoledronic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with zoledronic acid] results in increased expression of BAD protein | CTD | PMID:20349282 |
| zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of BAD mRNA | CTD | PMID:19036117 |